Medirom Healthcare TechnologMRM
13F holders, Q1 2026 (March 31)5holders +2
2new positions
0sold out
$1.11avg. 13F price*
At the end of Q1 2026, 5 institutions reported holding Medirom Healthcare Technolog (MRM) in their 13F filings, up 2 from Q4 2025. 2 opened new positions and 0 sold out. The largest holders were UBS Group AG ($30K), Two Sigma Securities, LLC ($16K) and HRT Financial LP ($13K).
- Company
- Medirom Healthcare Technolog
- CUSIP
- 58510H103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $29K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 48,814 shares bought and 6,415 shares sold, net +42,399 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| UBS Group AG | 0.00% | Add +634.2% | 26,548 | $30K |
| Two Sigma Securities, LLC | 0.00% | New | 13,977 | $16K |
| HRT Financial LP | 0.00% | New | 11,905 | $13K |
| GAMMA Investing LLC | 0.00% | Reduce -39.3% | 6,409 | $7K |
| Rhumbline Advisers | 0.00% | Reduce -53.4% | 1,984 | $2K |
"% of holder's portfolio" is MRM's weight in each manager's 13F, not the share of Medirom Healthcare Technolog the manager owns.